Literature DB >> 12068169

Adenocarcinomas arising from uterine adenomyosis: a report of four cases.

Masafumi Koshiyama1, Akira Suzuki, Mitsuru Ozawa, Kohei Fujita, Atsuko Sakakibara, Makoto Kawamura, Shugen Takahashi, Haruko Fujii, Takeshi Hirano, Atsuhiko Okagaki, Tadayoshi Nagano, Chiaki Ban.   

Abstract

Adenocarcinomas arising from adenomyosis uteri are rare. This study reports four such cases and characterizes them clinically and microscopically. In all four patients, the endometrial cytology was negative, and MR imaging and ultrasound sonography did not detect the tumors preoperatively. The histological subtypes of the four tumors were endometrioid (one grade 1, one grade 3), serous, and clear cell. In three cases, the adenocarcinomas were present exclusively in the myometrium, and a transition between the carcinomas and the adenomyotic glands was observed in all cases. The eutopic endometrium was normal except in one case in which there was a small focus of invasive carcinoma. In two of four cases, pelvic or paraaortic lymph node metastases were present. In the carcinomas, ER immunoreactivity was not found in any tumor and PR positivity was found in only one tumor. In contrast, p53 immunopositivity was found in three of four carcinomas. Adenocarcinomas arising from adenomyosis are difficult to diagnose preoperatively, and their aggressive behavior in some cases seems to be related to the histological subtype.

Entities:  

Mesh:

Year:  2002        PMID: 12068169     DOI: 10.1097/00004347-200207000-00006

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  9 in total

1.  Value of ultrasound shear wave elastography in the diagnosis of adenomyosis.

Authors:  S Acar; E Millar; M Mitkova; V Mitkov
Journal:  Ultrasound       Date:  2016-10-12

2.  Endometrioid adenocarcinoma arising in adenomyosis: elucidation by periodic magnetic resonance imaging evaluations.

Authors:  Kenichi Motohara; Hironori Tashiro; Hideyuki Ohtake; Fumitaka Saito; Takashi Ohba; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

3.  Adenomyosis: Back to the future?

Authors:  Z Ferraz; N Nogueira-Martins; F Nogueira-Martins
Journal:  Facts Views Vis Obgyn       Date:  2017-03

4.  Endometrioid adenocarcinoma originating simultaneously from endometrium, sites of adenomyosis and ovarian endometriosis: A case report and review of our cancer database.

Authors:  Lena Tashima; Kensuke Hori; Hitomi Ono; Teruaki Nagano; Shin-Ichi Nakatsuka; Kimihiko Ito
Journal:  Int J Surg Case Rep       Date:  2017-11-05

5.  Clear cell carcinomas of the mullerian system: does the pathogenesis vary depending on their nuclear grade and their association with endometriosis? An immunohistochemical analysis.

Authors:  Ahmad Alduaij; Katrine Hansen; Tahreem A Karim; Cunxian Zhang; Michelle M Lomme; C James Sung; W Dwayne Lawrence; M Ruhul Quddus
Journal:  Patholog Res Int       Date:  2012-11-01

6.  Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.

Authors:  Giacomo Puppa; Makio Shozu; Tiziana Perin; Kazuhito Nomura; Annunziata Gloghini; Elio Campagnutta; Vincenzo Canzonieri
Journal:  BMC Cancer       Date:  2007-06-20       Impact factor: 4.430

7.  A case of endometrioid adenocarcinoma arising from adenomyosis.

Authors:  Shigeki Taga; Mari Sawada; Aya Nagai; Dan Yamamoto; Ryoji Hayase
Journal:  Case Rep Obstet Gynecol       Date:  2014-02-10

8.  Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.

Authors:  Bingjian Lu; Qin Chen; Xiaofei Zhang; Lili Cheng
Journal:  Diagn Pathol       Date:  2016-06-04       Impact factor: 2.644

9.  IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.

Authors:  Aurelia Busca; Bojana Djordjevic; Ana Giassi; Carlos Parra-Herran
Journal:  Am J Clin Pathol       Date:  2016-03-21       Impact factor: 2.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.